WO2007011644A3 - Compositions for regenerating defective or absent tissue - Google Patents

Compositions for regenerating defective or absent tissue Download PDF

Info

Publication number
WO2007011644A3
WO2007011644A3 PCT/US2006/027212 US2006027212W WO2007011644A3 WO 2007011644 A3 WO2007011644 A3 WO 2007011644A3 US 2006027212 W US2006027212 W US 2006027212W WO 2007011644 A3 WO2007011644 A3 WO 2007011644A3
Authority
WO
WIPO (PCT)
Prior art keywords
organ
defective
damaged
compositions
extracellular matrix
Prior art date
Application number
PCT/US2006/027212
Other languages
French (fr)
Other versions
WO2007011644A2 (en
Inventor
Robert G Matheny
Original Assignee
Cormatrix Cardiovascular Inc
Robert G Matheny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/182,551 external-priority patent/US8568761B2/en
Priority claimed from US11/334,319 external-priority patent/US20070014868A1/en
Priority claimed from US11/334,631 external-priority patent/US20070014869A1/en
Application filed by Cormatrix Cardiovascular Inc, Robert G Matheny filed Critical Cormatrix Cardiovascular Inc
Publication of WO2007011644A2 publication Critical patent/WO2007011644A2/en
Publication of WO2007011644A3 publication Critical patent/WO2007011644A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]

Abstract

The invention is to a composition for reconstruction, replacement or repair of a defect or damage in organ tissue comprising an emulsion, injectable solution, patch or other compositions or material forms comprising extracellular matrix. The organ can be any organ in the human body, for example, heart, brain, liver, kidney, pancreas or spleen. The ability to address organ damage or defects using extracellular matrix materials, including using minimally invasive surgery to contact the extracellular matrix with the damaged or defective organ tissue provide the opportunity to regenerate, replace or repair damaged or defective organ tissue that would otherwise remain defective or damaged or which would function suboptimally compared to healthy organ tissue.
PCT/US2006/027212 2005-07-15 2006-07-12 Compositions for regenerating defective or absent tissue WO2007011644A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11/182,551 2005-07-15
US11/182,551 US8568761B2 (en) 2005-07-15 2005-07-15 Compositions for regenerating defective or absent myocardium
US11/334,319 US20070014868A1 (en) 2005-07-15 2006-01-18 Patch for reconstruction, replacement or repair of the pericardial sac
US11/334,631 US20070014869A1 (en) 2005-07-15 2006-01-18 Compositions for reconstruction, replacement or repair of intracardiac tissue
US11/334,319 2006-01-18
US11/334,631 2006-01-18

Publications (2)

Publication Number Publication Date
WO2007011644A2 WO2007011644A2 (en) 2007-01-25
WO2007011644A3 true WO2007011644A3 (en) 2007-08-02

Family

ID=37669358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/027212 WO2007011644A2 (en) 2005-07-15 2006-07-12 Compositions for regenerating defective or absent tissue

Country Status (1)

Country Link
WO (1) WO2007011644A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same
US8980296B2 (en) 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666852B2 (en) * 2002-04-22 2010-02-23 Agenta Biotechnologies, Inc. Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
US9532943B2 (en) 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
US11224635B2 (en) * 2007-03-27 2022-01-18 Venturis Thereuptics, Inc. Therapeutic angiogenesis for treatment of the spine and other tissues
US8983570B2 (en) 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
CN102488925A (en) * 2011-12-29 2012-06-13 成都普川生物医用材料股份有限公司 Injectable articular cartilage tissue repair material and its preparation method
US9801910B2 (en) 2014-03-17 2017-10-31 Ethicon, Inc. Decellularized pleural matrix
EP3122871B1 (en) * 2014-03-25 2020-09-02 Cook Biotech Incorporated Extracellular matrix grafts loaded with exogenous factors
WO2016123362A1 (en) 2015-01-30 2016-08-04 Northwestern University Artificial ovary
CN104984398B (en) * 2015-07-01 2018-03-30 上海交通大学医学院附属第九人民医院 A kind of preparation method and application of injection type tissue engineering bone gel carrier
US11491115B2 (en) 2015-07-09 2022-11-08 The Board Of Regents Of The University Of Texas System Nanoparticles containing extracellular matrix for drug delivery
CN107080861B (en) * 2017-03-03 2020-01-21 北京博辉瑞进生物科技有限公司 High-induction-activity repair material, preparation method and application

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5554389A (en) * 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US6099567A (en) * 1996-12-10 2000-08-08 Purdue Research Foundation Stomach submucosa derived tissue graft
WO2000061204A1 (en) * 1999-04-12 2000-10-19 Advanced Tissue Sciences, Inc. Three-dimensional stromal tissue
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2005042048A2 (en) * 2003-10-22 2005-05-12 Encelle, Inc. Bioactive hydrogel compositions for regenerating connective tissue
WO2006121532A2 (en) * 2005-03-31 2006-11-16 Mytogen, Inc. Treatment for heart disease

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5554389A (en) * 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US6099567A (en) * 1996-12-10 2000-08-08 Purdue Research Foundation Stomach submucosa derived tissue graft
WO2000061204A1 (en) * 1999-04-12 2000-10-19 Advanced Tissue Sciences, Inc. Three-dimensional stromal tissue
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2005042048A2 (en) * 2003-10-22 2005-05-12 Encelle, Inc. Bioactive hydrogel compositions for regenerating connective tissue
WO2006121532A2 (en) * 2005-03-31 2006-11-16 Mytogen, Inc. Treatment for heart disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980296B2 (en) 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same

Also Published As

Publication number Publication date
WO2007011644A2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
WO2007011644A3 (en) Compositions for regenerating defective or absent tissue
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
WO2010039823A3 (en) Compositions and methods for tissue repair with extracellular matrices
EP2664342A3 (en) Native (telopeptide) placental collagen compositions
WO2010054013A3 (en) Cell-scaffold constructs
WO2007062082A3 (en) Method and composition for repair and reconstruction of intervertebral discs and other reconstructive surgery
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
WO2005077013A3 (en) Surface directed cellular attachment
WO2007100530A3 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2012158952A8 (en) Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells and hydrogel
WO2006105167A3 (en) Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
GB2443938B (en) Preparation of tissue for meniscal implantation
WO2009136291A3 (en) Cellular extracts
WO2006135843A3 (en) Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
ATE395924T1 (en) RESTORATION OF DESTROYED TISSUE USING MULTIPOTENT CELLS
WO2009086305A3 (en) Osteoinductive putties and methods of making and using such putties
PL2184977T3 (en) Use of a globin, a globin protomer or an extracellular hemoglobin for the preservation of organs, tissues, organ and tissue cells
WO2005081870A3 (en) Intervertebral disc repair, methods and devices therefor
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2004039248A3 (en) Repairing or replacing tissues or organs
WO2008144021A3 (en) Ex vivo methods for validating substance testing with human organs and/or tissues
WO2010127254A3 (en) Thermoresponsive, biodegradable, elastomeric material and uses therefor
WO2009022133A3 (en) Scaffolds
DK1994939T3 (en) Pharmaceutical composition containing GHRP-6 for the prevention and elimination of fibrosis and other pathological deposits in tissues
WO2007025215A3 (en) Machine perfusion of tissue grafts for transplantation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06787156

Country of ref document: EP

Kind code of ref document: A2